BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 17045782)

  • 1. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways.
    Um M; Lodish HF
    J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells.
    Wenker SD; Chamorro ME; Vota DM; Callero MA; Vittori DC; Nesse AB
    J Cell Biochem; 2010 May; 110(1):151-61. PubMed ID: 20225234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells.
    Pregi N; Vittori D; Pérez G; Leirós CP; Nesse A
    Biochim Biophys Acta; 2006 Feb; 1763(2):238-46. PubMed ID: 16500719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
    McArthur GA; Longmore GD; Klingler K; Johnson GR
    Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of erythropoietin and its receptor in neuroblastomas.
    Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
    Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia.
    Knabe W; Sirén AL; Ehrenreich H; Kuhn HJ
    Anat Embryol (Berl); 2005 Oct; 210(3):209-19. PubMed ID: 16151855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
    Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
    Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span.
    Sanchez PE; Navarro FP; Fares RP; Nadam J; Georges B; Moulin C; Le Cavorsin M; Bonnet C; Ryvlin P; Belmeguenai A; Bodennec J; Morales A; Bezin L
    J Comp Neurol; 2009 Jun; 514(4):403-14. PubMed ID: 19330822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
    Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
    Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells.
    Pregi N; Wenker S; Vittori D; Leirós CP; Nesse A
    Exp Cell Res; 2009 Feb; 315(3):419-31. PubMed ID: 19056379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human erythropoietin receptor.
    Winkelmann JC
    Int J Cell Cloning; 1992 Sep; 10(5):254-61. PubMed ID: 1453011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of erythropoietin and its receptor in the developing midbrain.
    Knabe W; Knerlich F; Washausen S; Kietzmann T; Sirén AL; Brunnett G; Kuhn HJ; Ehrenreich H
    Anat Embryol (Berl); 2004 Mar; 207(6):503-12. PubMed ID: 14770308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane attenuates dynorphin-induced cytotoxicity and downregulation of Bcl-2 expression in differentiated neuroblastoma SH-SY5Y cells.
    Wu GJ; Chen WF; Sung CS; Jean YH; Hung CH; Chen FA; Hsieh MH; Wen ZH
    Acta Anaesthesiol Scand; 2009 Jan; 53(1):55-60. PubMed ID: 19032555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
    Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
    Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.